Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells

Pediatric Research

Volumn 75, Issue 4, 2014, Pages 482-486

  Shichrur, Keren ^a   Feinberg Gorenshtein, Galina ^a   Luria, Drorit ^b   Ash, Shifra ^b   Yaniv, Isaac ^a,b   Avigad, Smadar ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE COP1; UNCLASSIFIED DRUG; WD REPEAT AND SOCS BOX CONTAINING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; TUMOR XENOGRAFT;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICE; NEUROBLASTOMA; PROTEIN ISOFORMS; PROTEINS;

EID: 84896475114     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.2     Document Type: Article

References (17)

1. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-frst century. J Clin Oncol 2010;28:2625-34.
2. D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblas-toma with a favourable prognosis. Lancet 1971;1:1046-9.
3. De Bernardi B, Pianca C, Boni L, et al. Disseminated neuroblas-toma (stage IV and IV-S) in the frst year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer 1992;70:1625-33.
4. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010;362:2202-11.
5. Westermark UK, Wilhelm M, Frenzel A, Henriksson MA. The MYCN oncogene and diferentiation in neuroblastoma. Semin Cancer Biol 2011;21:256-66.
6. Gustafson WC, Weiss WA. Myc proteins as therapeutic targets. Oncogene 2010;29:1249-59.
7. Li MH, Hla T, Ferrer F. Sphingolipid modulation of angiogenic factor expression in neuroblastoma. Cancer Prev Res (Phila) 2011;4:1325-32.
8. Liberman J, Sartelet H, Flahaut M, et al. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblas-toma. PLoS ONE 2012;7:e43665.
9. Turner KE, Kumar HR, Hoelz DJ, et al. Proteomic analysis of neuroblas-toma microenvironment: effect of the host-tumor interaction on disease progression. J Surg Res 2009;156:116-22.
10. Archange C, Nowak J, Garcia S, et al. The WSB1 gene is involved in pancreatic cancer progression. PLoS ONE 2008;3:e2475.
11. Chen QR, Bilke S, Wei JS, et al. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuro-blastoma. Genes Chromosomes Cancer 2006;45:856-62.
12. David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010;24:2343-64.
13. Dentice M, Bandyopadhyay A, Gereben B, et al. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 2005;7:698-705.
14. Vasiliauskas D, Hancock S, Stern CD. SWiP-1: novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development. Mech Dev 1999;82:79-94.
15. Choi D W, Seo YM, Kim EA, et al. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 2008;283:4682-9.
16. Zeöld A, Pormüller L, Dentice M, et al. Metabolic instability of type 2 deio-dinase is transferable to stable proteins independently of subcellular localization. J Biol Chem 2006;281:31538-43
17. Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for fow cytometric DNA analysis. Cytometry 1983;3:323-7.